Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Gastric Cancer Diagnostic Procedure Market In The Coming Years?

There has been a significant increase in the market size for the diagnostic procedures for gastric cancer in recent times. It is projected to rise from $1.44 billion in 2024 to $1.54 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. The expansion witnessed in the historic period can be credited to the advancements in biopsy methods, heightened funding for research, progress in the identification of biomarkers, betterment of pathological evaluations, and alterations in screening guidelines.

In the coming years, the market for gastric cancer diagnostic procedures is predicted to experience substantial growth. By 2029, it should increase to a value of $2.06 billion, with a compound annual growth rate (CAGR) of 7.5%. This growth during the projected period can be linked to the surge in point-of-care testing, the emergence of new biomarkers, a move to more personalized medicine, the use of next-generation sequencing, and improved endoscopic imaging techniques. Notable trends expected during this forecast period encompass the incorporation of nanotechnology, the use of big data analytics, microbiota analysis applications, a greater focus on patient-centric strategies, and the importance of telehealth in diagnostics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Gastric Cancer Diagnostic Procedure Market?

The rise in gastrointestinal diseases is propelling the growth of the gastric cancer diagnostic procedure market. Gastrointestinal disorders entail health conditions impacting the many areas of the digestive system and the complementary organs like the liver and pancreas. Procedures used to diagnose stomach cancer, including endoscopic and biopsy methods, fall within the gastric cancer diagnostic procedure category. Consequently, the surge in gastrointestinal diseases is fostering the gastric cancer diagnostic procedure market’s expansion. For instance, in August 2022, GI Associates & Endoscopy Center, a US-based medical facility adept in gastroenterology services, disclosed a study involving 73,076 individuals from 33 countries. Alarmingly, 40% of the participants were battling a functional gastrointestinal disease. This growing frequency of gastrointestinal diseases henceforth amplifies the growth of the gastric cancer diagnostic procedure market.

Which Sub-Segments Are Driving Growth Within The Gastric Cancer Diagnostic Procedure Market?

The gastric cancer diagnostic proceduremarket covered in this report is segmented –

1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue Tests; Lab Tests; In-Vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays; Other Procedure Types

2) By Symptom Type: Symptomatic; Asymptomatic

3) By Offering Type: Instruments; Reagents And Consumables; Services

4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue; Other Body Fluid

5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer

Subsegments:

1) By Endoscopic Procedure: Upper Endoscopy (EGD); Endoscopic Ultrasound (EUS)

2) By Biopsy: Endoscopic Biopsy; Fine Needle Aspiration (FNA) Biopsy

3) By Tissue Tests: Histopathology; Immunohistochemistry

4) By Lab Tests: Blood Tests; Tumor Markers

5) By In-Vitro Diagnostic Tests: Genetic Testing; Molecular Profiling

6) By Imaging Tests: Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scan

7) By Molecular Diagnostics: PCR Testing; Next-Generation Sequencing (NGS)

8) By Multiplexing Molecular Diagnostics: Multiplex PCR; Microarray Analysis

9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)

10) By Other Procedure Types: Breath Tests; Liquid Biopsies

What Key Trends Are Driving Growth In The Gastric Cancer Diagnostic Procedure Market?

Emerging technologies are becoming increasingly significant in the gastric cancer diagnostic market, a trend that prominent corporations in the sector are exploiting to maintain their prominence. For example, in June 2022, Ibex Medical Analytics, an Israeli company specializing in AI-driven diagnostics for healthcare groups, introduced Galen Gastric, the planet’s first AI-assisted solution for the detection of gastric cancer. This integrated diagnostic tool aids pathologists in spotting stomach cancer, H. pylori, and other important clinical findings, while also expediting turnaround times and enhancing diagnostic workflows.

Which Players Are Shaping The Competitive Landscape Of The Gastric Cancer Diagnostic Procedure Market?

Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

How Do Regional Dynamics Influence The Gastric Cancer Diagnostic Procedure Market Performance?

North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Procedure Market 2025, By The Business Research Company

Transportation Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transportation-manufacturing-global-market-report

Truck Transportation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/truck-transportation-global-market-report

Commercial Vehicle Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/commercial-vehicle-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model